or
forgot password
  • cancer clinical trials in portland, OR

  • Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
    Oregon Health and Science University
    Portland, Oregon 97201
    Unspecified Childhood Solid Tumor, Protocol Specific
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Oregon Health & Science University
    Portland, Oregon 97201
    Chronic Myeloid Leukemia
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Northwest Cancer Specialists, P.C.
    Portland, Oregon 97227
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Currently Receiving and Progressing on Docetaxel Therapy
    OHSU Knight Cancer Institute
    Portland, Oregon 97239
    Adenocarcinoma of the Prostate, Castrate Resistant Prostate Cancer, Recurrent Prostate Cancer
    Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
    Oregon Health and Sciences Universtiy Cancer Center
    Portland, Oregon 97239
    Non-Small-Cell Lung Carcinoma
    Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
    Northwest Gastroenterology Clinic, LLC
    Portland, Oregon 97208
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Oregon Health and Science University
    Portland, Oregon 97201
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
    OHSU Knight Cancer Institute

    Trial Locations
    OHSU Knight Cancer Institute
    Portland VA Medical Center
    Prostate Cancer Prevention
    Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Oregon Health and Science University
    Kaiser Permanente
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Legacy Good Samaritan Hospital and Medical Center
    Portland, Oregon 97210
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Exercise and Stress Management Post Autologous and Allogeneic Transplant
    Oregon Health & Science University
    Portland, Oregon 97201
    Physiological Stress
    Safety & Health Improvement: Enhancing Law Enforcement Departments
    Oregon Health and Science University
    Portland, Oregon 97201
    Physical Activity, Nutrition, Health Promotion, Stress, Psychological, Cardiovascular Diseases, Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    Oregon Health and Science University
    Portland, Oregon 97201
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Northwest Cancer Specialists Vancouver Location
    Portland, Oregon 97210
    Non-small Cell Lung Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Head and Neck Cancer, Precancerous Condition
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Northwest Cancer Specialists, P.C.

    Trial Locations
    Northwest Cancer Specialists, P.C.
    Providence Cancer Center Oncology and Hematology Care
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
    OHSU Knight Cancer Institute
    Portland, Oregon 97239
    Conventional Chondrosarcoma
    A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma
    Oregon Health & Science University OHSU 2
    Portland, Oregon 97239
    BRAF or NRAS Mutant Metastatic Melanoma
    A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
    Oregon Health and Science University
    Portland, Oregon 97201
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease, Non-Hodgkin's Lymphoma
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    Northwest Cancer Specialists, PC
    Portland, Oregon 97225
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    Oregon Health and Science University
    Portland, Oregon 97201
    Recurrent Neuroblastoma
    Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
    The Oregon Clinic
    Portland, Oregon 97213
    Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
    Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
    Providence Health & Services
    Portland, Oregon 97213
    Locally Advanced Pancreatic Adenocarcinoma
    Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
    Oregon Health & Science University
    Portland, Oregon 97201
    Oropharyngeal Cancer, Human Papillomavirus
    Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
    Oregon Health & Science University
    Portland, Oregon 97201
    Colon Cancer
    Patients Treated for SCID (1968-2010)
    Oregon Health and Science University
    Portland, Oregon 97201
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
    Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
    Randall Children's Hospital at Legacy Emanuel
    Portland, Oregon 97227
    Central Nervous System Tumor, Pediatric, Chemotherapy-induced Nausea and Vomiting, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
    Synta Pharmaceuticals Investigative Site
    Portland, Oregon 97227
    Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, Non-small Cell Lung Cancer Metastatic
    A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
    Oregon Health and Science University
    Portland, Oregon 97201
    Chronic Myelomonocytic Leukemia
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Oregon Health & Science University/Doernbecher Children's Hospital
    Portland, Oregon 97239
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
    Oregon Health & Science University OHSU 3
    Portland, Oregon 97239
    Advanced Solid Tumors
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Providence Medical Center
    Portland, Oregon 97213
    Urothelial Carcinoma
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Portland, Oregon 97213
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Portland, Oregon 97213
    Muscle Wasting, Non-Small Cell Lung Cancer
    Phase I Biomarker Study (BMS-936558)
    Providence Portland Med Ctr
    Portland, Oregon 97213
    Renal Cell Carcinoma
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Kaiser Permanente NW
    Portland, Oregon
    Metastatic Pancreatic Adenocarcinoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Providence Portland Medical Center
    Portland, Oregon 97213-3635
    Non Small Cell Lung Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Prostate Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Oregon Health and Science University
    Portland, Oregon 97201
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies